CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors

Do-Youn Oh, Se-Hoon Lee, Sae-Won Han, Mi-Jung Kim, Tae-Min Kim, Tae-You Kim, Dae Seog Heo, Miyuki Yuasa, Yasuo Yanagihara, Yung-Jue Bang

Cancer Research and Treatment. 2015;47(4):607-615. Published online 2015 February 26 DOI: https://doi.org/10.4143/crt.2014.249

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors

Do-Youn Oh, Se-Hoon Lee, Sae-Won Han, Mi-Jung Kim, Tae-Min Kim, Tae-You Kim, Dae Seog Heo, Miyuki Yuasa, Yasuo Yanagihara, Yung-Jue Bang

Cancer Research and Treatment. 2015;47(4):607-615

Link1

Link2 Link3

Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors

Johanna C. Bendell, David S. Hong, Howard A. Burris, Aung Naing, Suzanne F. Jones, Gerald Falchook, Patricia Bricmont, Agnes Elekes, Edwin P. Rock, Razelle Kurzrock

Cancer Chemotherapy and Pharmacology. 2014;74(1):125-130

Link1

Link2 Link3 Link4

Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma

Takuji Okusaka, Hideki Ueno, Masafumi Ikeda, Shuichi Mitsunaga, Masato Ozaka, Hiroshi Ishii, Osamu Yokosuka, Yoshihiko Ooka, Ryo Yoshimoto, Yasuo Yanagihara, Kiwamu Okita

Hepatology Research. 2015;45(13):1283-1291

Link1 Link2

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma

Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo

Cancer Research and Treatment. 2019;51(2):510-518

Link1

Link2 Link3

1448 ORAL Molecular pharmacodynamic (MPD) phase I study with serial tumor and skin biopsies of the oral mTOR inhibitor Everolimus (E, RAD001) at different doses and schedules in patients (pts) with advanced solid tumors

European Journal of Cancer Supplements. 2005;3(2):419

Link1 Link2

238 oral Phase I study of combined treatment with the oral alkyl-phospholipid (APL) perifosine and radiation in patients with advanced solid tumors

Radiotherapy and Oncology. 2004;73:S108

Link1 Link2

A phase I and pharmacokinetic study of the farnesyl transferase inhibitor, CP-609,754 in patients with advanced solid tumors

European Journal of Cancer. 2002;38:S56

Link1 Link2

Phase I study of roniciclib (BAY1000394), an oral CDK inhibitor in Japanese patients with advanced solid tumors

Takashi Seto, Kaname Nosaki, Gen Shinoda, Kensei Hashizume, Iku Yamaguchi, Jun Tsuburaya, Hendrik Nogai, Kohei Shitara, Kiyotaka Yoh

Annals of Oncology. 2016;27:vii87-vii88

Link1 Link2 Link3

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors

Toshihiko Doi, Nobuaki Matsubara, Akira Kawai, Norifumi Naka, Shunji Takahashi, Hiroji Uemura, Noboru Yamamoto

Investigational New Drugs. 2019;38(4):1175-1185

Link1

Link2 Link3

Phase I Dose-Escalation Study of Oral Selective C-Met Inhibitor Emd 1214063 in Patients with Advanced Solid Tumors

G.S. Falchook, D.S. Hong, H.M. Amin, S. Fu, S.A. Piha-Paul, M.B. Klevesath, V. Jego, A. Johne, S. Stinchi, R. Kurzrock

Annals of Oncology. 2012;23:ix154

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.